ID

14428

Beschreibung

Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes; ODM derived from: https://clinicaltrials.gov/show/NCT02407262

Link

https://clinicaltrials.gov/show/NCT02407262

Stichworte

  1. 14.04.16 14.04.16 -
Hochgeladen am

14. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Asthma NCT02407262

Eligibility Asthma NCT02407262

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02407262
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult male/female (age 18-65 years),
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
partial and uncontrolled asthmatic patient based on gina guidelines (act score 5-20)
Beschreibung

Asthma Partial Uncontrolled | Asthma control test score

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0728938
UMLS CUI [1,3]
C0205318
UMLS CUI [2]
C2733224
no severe asthma exacerbation in the last 4 weeks
Beschreibung

Exacerbation of severe persistent asthma

Datentyp

boolean

Alias
UMLS CUI [1]
C3508930
able to obtain consent
Beschreibung

Ability Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with serious co-morbid conditions such as; cancer, renal, hepatic, cardio-vascular, gastrointestinal diseases, mental health conditions and respiratory disorder such as tb and copd.
Beschreibung

Comorbidity Severe | Malignant Neoplasms | Kidney Diseases | Liver diseases | Cardiovascular Diseases | Gastrointestinal Diseases | Mental disorders | Respiration Disorders | Tuberculosis | Chronic Obstructive Airway Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0006826
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0023895
UMLS CUI [5]
C0007222
UMLS CUI [6]
C0017178
UMLS CUI [7]
C0004936
UMLS CUI [8]
C0035204
UMLS CUI [9]
C0041296
UMLS CUI [10]
C0024117
smoking history
Beschreibung

Smoking History

Datentyp

boolean

Alias
UMLS CUI [1]
C1519384
pregnant women
Beschreibung

Patient currently pregnant

Datentyp

boolean

Alias
UMLS CUI [1]
C0549206
currently taking any form of black seed.
Beschreibung

Take Black Seed Oil

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1515187
UMLS CUI [1,2]
C2733644
known history of hypersensitivity to black seed.
Beschreibung

Hypersensitivity Black Seed Oil

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2733644
taking medications that may interact with black seed supplement: anticoagulant/antiplatelet, antidiabetic, antihypertensive, cns depressants, and immunosuppressant drugs
Beschreibung

Pharmaceutical Preparations Affecting Black Seed Oil Supplement | Anticoagulants | Antiplatelet Agents | Antidiabetics | Antihypertensive Agents | Central Nervous System Depressants | Immunosuppressive Agents

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2733644
UMLS CUI [1,4]
C2348609
UMLS CUI [2]
C0003280
UMLS CUI [3]
C0085826
UMLS CUI [4]
C0935929
UMLS CUI [5]
C0003364
UMLS CUI [6]
C0007681
UMLS CUI [7]
C0021081

Ähnliche Modelle

Eligibility Asthma NCT02407262

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02407262
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
adult male/female (age 18-65 years),
boolean
C0001779 (UMLS CUI [1])
Asthma Partial Uncontrolled | Asthma control test score
Item
partial and uncontrolled asthmatic patient based on gina guidelines (act score 5-20)
boolean
C0004096 (UMLS CUI [1,1])
C0728938 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C2733224 (UMLS CUI [2])
Exacerbation of severe persistent asthma
Item
no severe asthma exacerbation in the last 4 weeks
boolean
C3508930 (UMLS CUI [1])
Ability Informed Consent
Item
able to obtain consent
boolean
C0085732 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Comorbidity Severe | Malignant Neoplasms | Kidney Diseases | Liver diseases | Cardiovascular Diseases | Gastrointestinal Diseases | Mental disorders | Respiration Disorders | Tuberculosis | Chronic Obstructive Airway Disease
Item
patients with serious co-morbid conditions such as; cancer, renal, hepatic, cardio-vascular, gastrointestinal diseases, mental health conditions and respiratory disorder such as tb and copd.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0006826 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0007222 (UMLS CUI [5])
C0017178 (UMLS CUI [6])
C0004936 (UMLS CUI [7])
C0035204 (UMLS CUI [8])
C0041296 (UMLS CUI [9])
C0024117 (UMLS CUI [10])
Smoking History
Item
smoking history
boolean
C1519384 (UMLS CUI [1])
Patient currently pregnant
Item
pregnant women
boolean
C0549206 (UMLS CUI [1])
Take Black Seed Oil
Item
currently taking any form of black seed.
boolean
C1515187 (UMLS CUI [1,1])
C2733644 (UMLS CUI [1,2])
Hypersensitivity Black Seed Oil
Item
known history of hypersensitivity to black seed.
boolean
C0020517 (UMLS CUI [1,1])
C2733644 (UMLS CUI [1,2])
Pharmaceutical Preparations Affecting Black Seed Oil Supplement | Anticoagulants | Antiplatelet Agents | Antidiabetics | Antihypertensive Agents | Central Nervous System Depressants | Immunosuppressive Agents
Item
taking medications that may interact with black seed supplement: anticoagulant/antiplatelet, antidiabetic, antihypertensive, cns depressants, and immunosuppressant drugs
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2733644 (UMLS CUI [1,3])
C2348609 (UMLS CUI [1,4])
C0003280 (UMLS CUI [2])
C0085826 (UMLS CUI [3])
C0935929 (UMLS CUI [4])
C0003364 (UMLS CUI [5])
C0007681 (UMLS CUI [6])
C0021081 (UMLS CUI [7])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video